BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Panasiuk A, Dzieciol J, Panasiuk B, Prokopowicz D. Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease. World J Gastroenterol 2006; 12(38): 6198-6202 [PMID: 17036395 DOI: 10.3748/wjg.v12.i38.6198]
URL: https://www.wjgnet.com/1007-9327/full/v12/i38/6198.htm
Number Citing Articles
1
Bre-Anne Fifield, John Talia, Carlee Stoyanovich, Mitchell J Elliott, Martin K Bakht, Amy Basilious, Joshua P Samsoondar, Madison Curtis, Keith F Stringer, Lisa A Porter. Cyclin-like proteins tip regenerative balance in the liver to favour cancer formationCarcinogenesis 2020; 41(6): 850 doi: 10.1093/carcin/bgz164
2
Shakir D. AlSharari, Salim S. Al-Rejaie, Hatem M. Abuohashish, Mohamed M. Ahmed, Mohamed M. Hafez. Rutin Attenuates Hepatotoxicity in High-Cholesterol-Diet-Fed RatsOxidative Medicine and Cellular Longevity 2016; 2016: 1 doi: 10.1155/2016/5436745
3
Xi Jin, Jiang Liu, Yi-peng Chen, Zun Xiang, Jie-xia Ding, You-ming Li, Patricia Aspichueta. Effect of miR-146 targeted HDMCP up-regulation in the pathogenesis of nonalcoholic steatohepatitisPLOS ONE 2017; 12(3): e0174218 doi: 10.1371/journal.pone.0174218
4
Kai Liu, Jinli Lou, Tao Wen, Jiming Yin, Bin Xu, Wei Ding, Anna Wang, Daojie Liu, Chao Zhang, Dexi Chen, Ning Li. Depending on the stage of hepatosteatosis, p53 causes apoptosis primarily through either DRAM‐induced autophagy or BAXLiver International 2013; 33(10): 1566 doi: 10.1111/liv.12238
5
Atilla Engin. Obesity and LipotoxicityAdvances in Experimental Medicine and Biology 2017; 960: 443 doi: 10.1007/978-3-319-48382-5_19
6
Xiaoqing Luo, Jianye Zhang, Yue Gao, Weifei Pan, Yayuan Yang, Xu Li, Lingfei Chen, Chang Wang, Yuqing Wang. Emerging roles of i-motif in gene expression and disease treatmentFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1136251
7
Laila Naif Al-Harbi, Ghedeir M. Alshammari, Alhanouf Mohammed Al-Dossari, Pandurangan Subash-Babu, Manal Abdulaziz Binobead, Maha H. Alhussain, Sahar Abdulaziz AlSedairy, Doha M. Al-Nouri, Ghalia Shamlan. Beta vulgaris L. (Beetroot) Methanolic Extract Prevents Hepatic Steatosis and Liver Damage in T2DM Rats by Hypoglycemic, Insulin-Sensitizing, Antioxidant Effects, and Upregulation of PPARαBiology 2021; 10(12): 1306 doi: 10.3390/biology10121306
8
Michael H. Miller, Michael A. J. Ferguson, John F. Dillon. Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver diseaseLiver International 2011; 31(4): 461 doi: 10.1111/j.1478-3231.2011.02451.x
9
Geoffrey C Farrell, Claire Z Larter, Jing Yun Hou, Rena H Zhang, Matthew M Yeh, Jacqueline Williams, Aileen Dela Peňa, Rona Francisco, Sarah R Osvath, John Brooling, Narcissus Teoh, Lisa M Sedger. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expressionJournal of Gastroenterology and Hepatology 2009; 24(3): 443 doi: 10.1111/j.1440-1746.2009.05785.x
10
Wenjun Lin, Xin Zhang, Chuan Zhang, Li Li, Jing Zhang, Ping Xie, Yutao Zhan, Wei An. Deletion of Smurf1 attenuates liver steatosis via stabilization of p53Laboratory Investigation 2022; 102(10): 1075 doi: 10.1038/s41374-022-00802-x
11
Sevil A. Grabeklis, Liudmila M. Mikhaleva, Maria A. Kozlova, David A. Areshidze, Alexander M. Dygai. Influence of constant lighting on the morphofunctional state and rhythmostasis of the liver of ratsMedical academic journal 2023; 23(2): 63 doi: 10.17816/MAJ322855
12
Cornelius Engelmann, Frank Tacke. The Potential Role of Cellular Senescence in Non-Alcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2022; 23(2): 652 doi: 10.3390/ijms23020652
13
Wing-Kin Syn, Steve S. Choi, Anna Mae Diehl. Apoptosis and Cytokines in Non-Alcoholic SteatohepatitisClinics in Liver Disease 2009; 13(4): 565 doi: 10.1016/j.cld.2009.07.003
14
Catherine Brenner, Lorenzo Galluzzi, Oliver Kepp, Guido Kroemer. Decoding cell death signals in liver inflammationJournal of Hepatology 2013; 59(3): 583 doi: 10.1016/j.jhep.2013.03.033
15
Qiushi Xu, Yunhui Fan, Juan J. Loor, Yusheng Liang, Hongming Lv, Xudong Sun, Hongdou Jia, Chuang Xu. Aloin protects mice from diet-induced non-alcoholic steatohepatitis via activation of Nrf2/HO-1 signalingFood & Function 2021; 12(2): 696 doi: 10.1039/D0FO02684K
16
Mathias Flensted-Jensen, Denise Oró, Emma A. Rørbeck, Chen Zhang, Martin Rønn Madsen, Andreas Nygaard Madsen, Jenny Norlin, Michael Feigh, Steen Larsen, Henrik H. Hansen. Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASHBMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03141-x
17
Hanan El Bassat, Dina H. Ziada, Eiman A. Hasby, Hala Nagy, Mohammad H. Abo Ryia. Apoptotic and anti-apoptotic seromarkers for assessment of disease severity of non-alcoholic steatohepatitisArab Journal of Gastroenterology 2014; 15(1): 6 doi: 10.1016/j.ajg.2014.01.009
18
Heechul Nam, Ji Lim, Tae Kim, Eun Kim, Sae-Jong Oum, Si Bae, Cheol Park. Extracellular Superoxide Dismutase Attenuates Hepatic Oxidative Stress in Nonalcoholic Fatty Liver Disease through the Adenosine Monophosphate-Activated Protein Kinase ActivationAntioxidants 2023; 12(12): 2040 doi: 10.3390/antiox12122040
19
Yuxiang Song, Xinwei Li, Yu Li, Na Li, Xiaoxia Shi, Hongyan Ding, Yuhang Zhang, Xiaobing Li, Guowen Liu, Zhe Wang. Non-esterified fatty acids activate the ROS–p38–p53/Nrf2 signaling pathway to induce bovine hepatocyte apoptosis in vitroApoptosis 2014; 19(6): 984 doi: 10.1007/s10495-014-0982-3
20
Tianhua He, Nikita Lykov, Xu Luo, Huiling Wang, Zhanxiang Du, Ziyi Chen, Shitian Chen, Lin Zhu, Ye Zhao, Chimeng Tzeng. Protective Effects of Lactobacillus gasseri against High-Cholesterol Diet-Induced Fatty Liver and Regulation of Host Gene Expression ProfilesInternational Journal of Molecular Sciences 2023; 24(3): 2053 doi: 10.3390/ijms24032053
21
Kengo Tomita, Toshiaki Teratani, Takahiro Suzuki, Tetsuya Oshikawa, Hirokazu Yokoyama, Katsuyoshi Shimamura, Kiyoshi Nishiyama, Norikazu Mataki, Rie Irie, Tohru Minamino, Yoshikiyo Okada, Chie Kurihara, Hirotoshi Ebinuma, Hidetsugu Saito, Ippei Shimizu, Yohko Yoshida, Ryota Hokari, Kazuo Sugiyama, Kazuo Hatsuse, Junji Yamamoto, Takanori Kanai, Soichiro Miura, Toshifumi Hibi. p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and miceJournal of Hepatology 2012; 57(4): 837 doi: 10.1016/j.jhep.2012.05.013
22
Marco Bertolotti, Amedeo Lonardo, Chiara Mussi, Enrica Baldelli, Elisa Pellegrini, Stefano Ballestri, Dante Romagnoli, Paola Loria. Nonalcoholic fatty liver disease and aging: Epidemiology to managementWorld Journal of Gastroenterology 2014; 20(39): 14185-14204 doi: 10.3748/wjg.v20.i39.14185
23
Elisa Melucci, Maurizio Cosimelli, Livio Carpanese, Giuseppe Pizzi, Francesco Izzo, Francesco Fiore, Rita Golfieri, Emanuela Giampalma, Isabella Sperduti, Cristiana Ercolani, Rosa Sciuto, Raffaello Mancini, Carlo Garufi, Maria Grazia Diodoro, Marcella Mottolese. Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity after radioembolization with yttrium-90 resin microspheresJournal of Experimental & Clinical Cancer Research 2013; 32(1) doi: 10.1186/1756-9966-32-13
24
Robert Vincent, Arun Sanyal. Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and PlayersCurrent Pathobiology Reports 2014; 2(3): 109 doi: 10.1007/s40139-014-0049-8
25
Mariana Verdelho Machado, Helena Cortez-Pinto. Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?Expert Review of Gastroenterology & Hepatology 2011; 5(2): 213 doi: 10.1586/egh.11.16
26
Johanna Pedroza-Diaz, Johanna C. Arroyave-Ospina, Sandra Serna Salas, Han Moshage. Modulation of Oxidative Stress-Induced Senescence during Non-Alcoholic Fatty Liver DiseaseAntioxidants 2022; 11(5): 975 doi: 10.3390/antiox11050975
27
Óscar Osorio-Conles, Arturo Vega-Beyhart, Ainitze Ibarzabal, José María Balibrea, Isabel Graupera, Jordi Rimola, Josep Vidal, Ana de Hollanda. A Distinctive NAFLD Signature in Adipose Tissue from Women with Severe ObesityInternational Journal of Molecular Sciences 2021; 22(19): 10541 doi: 10.3390/ijms221910541
28
Sherif Mohamed Zaki, Dania S. Waggas. Protective Effect of Nigella sativa and Onion Extract against 5-Fluorouracil-Induced Hepatic ToxicityNutrition and Cancer 2022; 74(7): 2657 doi: 10.1080/01635581.2021.2019794
29
Tan Khanh Nguyen, Huy Hieu Phung, Won Jun Choi, Hee-Chul Ahn. Network Pharmacology and Molecular Docking Study on the Multi-Target Mechanisms of Aloe vera for Non-Alcoholic Steatohepatitis TreatmentPlants 2022; 11(24): 3585 doi: 10.3390/plants11243585
30
Chawon Yun, Sou Hyun Kim, Doyoung Kwon, Mi Ran Byun, Ki Wung Chung, Jaewon Lee, Young-Suk Jung. Doxorubicin Attenuates Free Fatty Acid-Induced Lipid Accumulation via Stimulation of p53 in HepG2 CellsBiomolecules & Therapeutics 2024; 32(1): 94 doi: 10.4062/biomolther.2023.200
31
Justyna Strycharz, Jozef Drzewoski, Janusz Szemraj, Agnieszka Sliwinska. Is p53 Involved in Tissue-Specific Insulin Resistance Formation?Oxidative Medicine and Cellular Longevity 2017; 2017: 1 doi: 10.1155/2017/9270549
32
Matthieu Lacroix, Romain Riscal, Giuseppe Arena, Laetitia Karine Linares, Laurent Le Cam. Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancerMolecular Metabolism 2020; 33: 2 doi: 10.1016/j.molmet.2019.10.002
33
Vlasta Demeckova, Dagmar Mudronova, Sona Gancarcikova, Peter Kubatka, Karol Kajo, Monika Kassayova, Bianka Bojkova, Marian Adamkov, Peter Solár. 5-Fluorouracil Treatment of CT26 Colon Cancer Is Compromised by Combined Therapy with IMMODINInternational Journal of Molecular Sciences 2022; 23(12): 6374 doi: 10.3390/ijms23126374
34
Xiaoli Pan, Yanqiao Zhang. Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver diseaseChinese Medical Journal 2022; 135(10): 1172 doi: 10.1097/CM9.0000000000002092
35
Karen Louise Thomsen, Peter Lykke Eriksen, Annarein JC. Kerbert, Francesco De Chiara, Rajiv Jalan, Hendrik Vilstrup. Role of ammonia in NAFLD: An unusual suspectJHEP Reports 2023; 5(7): 100780 doi: 10.1016/j.jhepr.2023.100780
36
Elisabeth Rohbeck, Corinna Niersmann, Karl Köhrer, Thorsten Wachtmeister, Michael Roden, Jürgen Eckel, Tania Romacho. Positive allosteric GABAA receptor modulation counteracts lipotoxicity-induced gene expression changes in hepatocytes in vitroFrontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1106075
37
Lijun Pang, Kai Liu, Daojie Liu, Fudong Lv, Yunjin Zang, Fang Xie, Jiming Yin, Ying Shi, Yanjun Wang, Dexi Chen. Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver diseaseCell Death & Disease 2018; 9(2) doi: 10.1038/s41419-017-0136-y
38
Zohreh Khajehahmadi, Heidar Tavilani, Jamshid Karimi, Mohammad Rafiee, Zahra Arab-Sadeghabadi, Roohollah Mohseni, Sina Mohagheghi. Non-Alcoholic Steatohepatitis and Autoimmune Hepatitis Cirrhosis May Have a Higher Risk of Progression to Hepatocellular CarcinomaHepatitis Monthly 2023; (In Press) doi: 10.5812/hepatmon-138449
39
Wensheng Liu, Robert D. Baker, Tavleen Bhatia, Lixin Zhu, Susan S. Baker. Pathogenesis of nonalcoholic steatohepatitisCellular and Molecular Life Sciences 2016; 73(10): 1969 doi: 10.1007/s00018-016-2161-x
40
Lijuan Xue, Keanqi Liu, Caixia Yan, Junling Dun, Yexin Xu, Linlin Wu, Huizhu Yang, Huafang Liu, Lin Xie, Guangji Wang, Yan Liang. Schisandra lignans ameliorate nonalcoholic steatohepatitis by regulating aberrant metabolism of phosphatidylethanolaminesActa Pharmaceutica Sinica B 2023; 13(8): 3545 doi: 10.1016/j.apsb.2023.04.009
41
Xiaoya Li, Jing Wang, Xue Gong, Meiling Zhang, Shuangshuang Kang, Bing Shu, Zuzhuang Wei, Zhi-Shu Huang, Ding Li. Upregulation of BCL-2 by acridone derivative through gene promoter i-motif for alleviating liver damage of NAFLD/NASHNucleic Acids Research 2020; 48(15): 8255 doi: 10.1093/nar/gkaa615
42
Sarah M. Alsuliam, Nawal A. Albadr, Salah A. Almaiman, Abdullrahman S. Al-Khalifah, Noorah S. Alkhaldy, Ghedeir M. Alshammari. Fenugreek Seed Galactomannan Aqueous and Extract Protects against Diabetic Nephropathy and Liver Damage by Targeting NF-κB and Keap1/Nrf2 AxisToxics 2022; 10(7): 362 doi: 10.3390/toxics10070362
43
Meital Charni, Noa Rivlin, Alina Molchadsky, Ronit Aloni-Grinstein, Varda Rotter. p53 in liver pathologies—taking the good with the badJournal of Molecular Medicine 2014; 92(12): 1229 doi: 10.1007/s00109-014-1223-5
44
Huiling Wu, Xi Song, Yuntao Ling, Jin Zhou, Zhen Tao, Yuying Shen. Comprehensive bioinformatics analysis of critical lncRNAs, mRNAs and miRNAs in non‑alcoholic fatty liver diseaseMolecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.9931
45
Yanyong Xu, Yingdong Zhu, Shuwei Hu, Yang Xu, Diane Stroup, Xiaoli Pan, Fathima Cassim Bawa, Shaoru Chen, Raja Gopoju, Liya Yin, Yanqiao Zhang. Hepatocyte Nuclear Factor 4α Prevents the Steatosis‐to‐NASH Progression by Regulating p53 and Bile Acid Signaling (in mice)Hepatology 2021; 73(6): 2251 doi: 10.1002/hep.31604
46
Xuequn Zhang, Yiming Lin, Sisi Lin, Chunxiao Li, Jianguo Gao, Zemin Feng, Jinghua Wang, Jie Zhang, Hong Zhang, Yuwei Zhang, Xueyang Chen, Shenghui Chen, Chengfu Xu, Youming Li, Chaohui Yu, Hang Zeng. Silencing of functional p53 attenuates NAFLD by promoting HMGB1-related autophagy inductionHepatology International 2020; 14(5): 828 doi: 10.1007/s12072-020-10068-4
47
Rui E. Castro, Duarte M.S. Ferreira, Marta B. Afonso, Pedro M. Borralho, Mariana V. Machado, Helena Cortez-Pinto, Cecília M.P. Rodrigues. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver diseaseJournal of Hepatology 2013; 58(1): 119 doi: 10.1016/j.jhep.2012.08.008
48
Kinya Okamoto, Masahiko Koda, Toshiaki Okamoto, Takumi Onoyama, Kenichi Miyoshi, Manabu Kishina, Tomomitsu Matono, Jun Kato, Shiho Tokunaga, Takaaki Sugihara, Akira Hiramatsu, Hideyuki Hyogo, Hiroshi Tobita, Shuichi Sato, Miwa Kawanaka, Yuichi Hara, Keisuke Hino, Kazuaki Chayama, Yoshikazu Murawaki, Hajime Isomoto, Catherine Mounier. Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver diseasePLOS ONE 2020; 15(2): e0219412 doi: 10.1371/journal.pone.0219412
49
Shahar Azar, Shiran Udi, Adi Drori, Rivka Hadar, Alina Nemirovski, Kiran V. Vemuri, Maya Miller, Dana Sherill-Rofe, Yhara Arad, Devorah Gur-Wahnon, Xiaoling Li, Alexandros Makriyannis, Danny Ben-Zvi, Yuval Tabach, Iddo Z. Ben-Dov, Joseph Tam. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependentMolecular Metabolism 2020; 42: 101087 doi: 10.1016/j.molmet.2020.101087
50
Denada Dibra, Xueqing Xia, Abhisek Mitra, Jeffry J. Cutrera, Guillermina Lozano, Shulin Li. Mutant p53 in concert with an interleukin‐27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in miceHepatology 2016; 63(3): 1000 doi: 10.1002/hep.28379
51
Basile Keshavjee, Valentine Lambelet, Hanna Coppola, David Viertl, John O. Prior, Laurent Kappeler, Jean-Baptiste Armengaud, Jean-Pierre Chouraqui, Hassib Chehade, Paul-Emmanuel Vanderriele, Manon Allouche, Anne Balsiger, Alexandre Sarre, Anne-Christine Peyter, Umberto Simeoni, Catherine Yzydorczyk. Stress-Induced Premature Senescence Related to Oxidative Stress in the Developmental Programming of Nonalcoholic Fatty Liver Disease in a Rat Model of Intrauterine Growth RestrictionAntioxidants 2022; 11(9): 1695 doi: 10.3390/antiox11091695
52
Anil C. Anand, Subrat K. Acharya. The Story of Ammonia in Liver Disease: An Unraveling ContinuumJournal of Clinical and Experimental Hepatology 2024; 14(4): 101361 doi: 10.1016/j.jceh.2024.101361
53
Heng Wu, Raymond Ng, Xin Chen, Clifford J Steer, Guisheng Song. MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathwayGut 2016; 65(11): 1850 doi: 10.1136/gutjnl-2014-308430
54
Chongyang Ma, Mengpei Zhao, Yuqiong Du, Shuang Jin, Xiaoyi Wu, Haiyan Zou, Qiuyun Zhang, Lianyin Gao, Chih-Yuan Ko. Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Qingdu Decoction against Chronic Liver InjuryEvidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/6661667
55
Christopher L. Gentile, Melinda A. Frye, Michael J. Pagliassotti. Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver diseaseBioFactors 2011; 37(1): 8 doi: 10.1002/biof.135
56
Zoltan Derdak, Kristine A. Villegas, Ragheb Harb, Annie M. Wu, Aryanna Sousa, Jack R. Wands. Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver diseaseJournal of Hepatology 2013; 58(4): 785 doi: 10.1016/j.jhep.2012.11.042
57
Zhibin Yan, Xiaokang Miao, Bangzhi Zhang, Junqiu Xie. p53 as a double-edged sword in the progression of non-alcoholic fatty liver diseaseLife Sciences 2018; 215: 64 doi: 10.1016/j.lfs.2018.10.051
58
Jelena Krstic, Markus Galhuber, Tim Schulz, Michael Schupp, Andreas Prokesch. p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the MedicineInternational Journal of Molecular Sciences 2018; 19(3): 921 doi: 10.3390/ijms19030921
59
Itziar Frades, Erik Andreasson, Jose Maria Mato, Erik Alexandersson, Rune Matthiesen, Mª Luz Martínez-Chantar, Matias A Avila. Integrative Genomic Signatures Of Hepatocellular Carcinoma Derived from Nonalcoholic Fatty Liver DiseasePLOS ONE 2015; 10(5): e0124544 doi: 10.1371/journal.pone.0124544
60
Toshihiro Goto, Michiko Itoh, Takayoshi Suganami, Sayaka Kanai, Ibuki Shirakawa, Takeru Sakai, Masahiro Asakawa, Toshihiro Yoneyama, Toshihiro Kai, Yoshihiro Ogawa. Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitisScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-26383-8
61
Siyu Yu, Guang Ji, Li Zhang. The role of p53 in liver fibrosisFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1057829
62
Clémence M. Canivet, Stéphanie Bonnafous, Déborah Rousseau, Pierre S. Leclere, Sandra Lacas-Gervais, Stéphanie Patouraux, Arnaud Sans, Carmelo Luci, Béatrice Bailly-Maitre, Antonio Iannelli, Albert Tran, Rodolphe Anty, Philippe Gual. Hepatic FNDC5 is a potential local protective factor against Non-Alcoholic Fatty LiverBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(5): 165705 doi: 10.1016/j.bbadis.2020.165705
63
Han Xue, Di Chen, Yan‐Ke Zhong, Zhen‐Diao Zhou, Shi‐Xin Fang, Ming‐Yao Li, Chuang Guo. Deferoxamine ameliorates hepatosteatosis via several mechanisms in ob/ob miceAnnals of the New York Academy of Sciences 2016; 1375(1): 52 doi: 10.1111/nyas.13174
64
Nabil Mohie Abdel-Hamid, Ahmed Wahid, Maiiada Hassan Nazmy, Marwa Abdel-Moniem Eisa. Synergistic Effects of Jerusalem Artichoke in Combination with Pegylated Interferon Alfa-2a and Ribavirin Against Hepatic Fibrosis in RatsAsian Pacific Journal of Cancer Prevention 2016; 17(4): 1979 doi: 10.7314/APJCP.2016.17.4.1979
65
Weigang Yuan, Mi Zhang, Chunxu Wang, Bin Li, Lei Li, Feng Ye, Chuanrui Xu. Resveratrol Attenuates High-Fat Diet–Induced Hepatic Lipotoxicity by Upregulating Bmi-1 ExpressionJournal of Pharmacology and Experimental Therapeutics 2022; 381(2): 96 doi: 10.1124/jpet.121.001018
66
Huanyu Lu, Linni Fan, Wenli Zhang, Guo Chen, An Xiang, Li Wang, Zifan Lu, Yue Zhai. The mitochondrial genome-encoded peptide MOTS-c interacts with Bcl-2 to alleviate nonalcoholic steatohepatitis progressionCell Reports 2024; 43(1): 113587 doi: 10.1016/j.celrep.2023.113587
67
Takahiro Kodama, Tetsuo Takehara, Hayato Hikita, Satoshi Shimizu, Minoru Shigekawa, Hinako Tsunematsu, Wei Li, Takuya Miyagi, Atsushi Hosui, Tomohide Tatsumi, Hisashi Ishida, Tatsuya Kanto, Naoki Hiramatsu, Satoshi Kubota, Masaharu Takigawa, Yoshito Tomimaru, Akira Tomokuni, Hiroaki Nagano, Yuichiro Doki, Masaki Mori, Norio Hayashi. Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in miceJournal of Clinical Investigation 2011; 121(8): 3343 doi: 10.1172/JCI44957
68
Jozaa Z. ALTamimi, Ghedeir M. Alshammari, Nora A. AlFaris, Reham I. Alagal, Dalal H. Aljabryn, Norah A. Albekairi, Mahmoud Ahmad Alkhateeb, Mohammed Abdo Yahya. Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPKPharmaceutical Biology 2022; 60(1): 25 doi: 10.1080/13880209.2021.1990969
69
Jialing Wu, Chong Chen, Xi Hu, Xianbin Cai, Yinghong Guan, Hui Hu, Qinjia Wang, Xiaofeng Chen, Bozhi Cai, Xubin Jing. Suppressing Cyclooxygenase-2 Prevents nonalcoholic and inhibits apoptosis of hepatocytes that are involved in the Akt/p53 signal pathwayBiochemical and Biophysical Research Communications 2016; 469(4): 1034 doi: 10.1016/j.bbrc.2015.12.096
70
Shimaa Mohammad Yousof, Horeya Erfan, Marwa Mohamed Hosny, Shaimaa A. Shehata, Karima El-Sayed. Subacute toxic effects of silver nanoparticles oral administration and withdrawal on the structure and function of adult Albino Rats’ hepatic tissueSaudi Journal of Biological Sciences 2022; 29(5): 3890 doi: 10.1016/j.sjbs.2022.02.054
71
EmanA Abd Elmaogod, Azza Hegazy, AblaS Mahmoud, Ibrahim Marwan, Osama Hegazy, Mohamed El-Abgeegy, HebaF Elsergany, EmanI El-Desoki Mahmoud, AmalA Mohamed, HossamE M Soliman, MohamedI Seleem, ShawkatS Gerges, Ahmed Albotaly, Ahmed Hamdy, Heba Abdelaziz, Amr Abdelraouf. Clinicopathological analysis of ischemia/reperfusion time-zero injury biopsies and its role in early allograft dysfunction in hepatic transplantation (retrospective cross-sectional study)Egyptian Journal of Pathology 2022; 42(2): 131 doi: 10.4103/egjp.egjp_14_22
72
Ying Wan, Tianhao Zhou, Elise Slevin, Sachiko Koyama, Xuedong Li, Kelly Harrison, Tian Li, Bingru Zhou, Sugeily Ramos Lorenzo, Yudian Zhang, Wenjuan Xu, James E. Klaunig, Chaodong Wu, Ashok K. Shetty, Chiung‐Kuei Huang, Fanyin Meng. Liver‐specific deletion of microRNA‐34a alleviates ductular reaction and liver fibrosis during experimental cholestasisThe FASEB Journal 2023; 37(2) doi: 10.1096/fj.202201453R
73
Fatemeh Mirzaei, Ebrahim Abbasi, Amir Mirzaei, Nashmin Fayazi Hosseini, Nima Naseri, Iraj Khodadadi, Cyrus Jalili, Nesrine Majdoub. Toxicity and Hepatoprotective Effects of ZnO Nanoparticles on Normal and High-Fat Diet-Fed Rat Livers: Mechanism of ActionBiological Trace Element Research 2024;  doi: 10.1007/s12011-024-04108-5
74
Stefan H. Luijmes, Roberto Broere, Jeroen de Jonge. The Liver Graft Before Transplantation2024; : 187 doi: 10.1016/B978-0-323-99655-6.00005-1
75
Mario Arciello, Alessia Longo, Carmela Viscomi, Concetta Capo, Antonio Angeloni, Luisa Rossi, Clara Balsano. Core domain mutant Y220C of p53 protein has a key role in copper homeostasis in case of free fatty acids overloadBioMetals 2015; 28(6): 1017 doi: 10.1007/s10534-015-9886-0
76
Hiroya Yamada, Koji Suzuki, Naohiro Ichino, Yoshitaka Ando, Akira Sawada, Keisuke Osakabe, Keiko Sugimoto, Koji Ohashi, Ryouji Teradaira, Takashi Inoue, Nobuyuki Hamajima, Shuji Hashimoto. Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liverClinica Chimica Acta 2013; 424: 99 doi: 10.1016/j.cca.2013.05.021
77
Che-Pei Kung, Maureen E Murphy. The role of the p53 tumor suppressor in metabolism and diabetesJournal of Endocrinology 2016; 231(2): R61 doi: 10.1530/JOE-16-0324
78
Pengzu Wang, Zhuang Lu, Meng He, Baoming Shi, Xingen Lei, Anshan Shan. The Effects of Endoplasmic-Reticulum-Resident Selenoproteins in a Nonalcoholic Fatty Liver Disease Pig Model Induced by a High-Fat DietNutrients 2020; 12(3): 692 doi: 10.3390/nu12030692
79
Leila Kheirandish-Gozal, Oscar Sans Capdevila, Ebrahim Kheirandish, David Gozal. Elevated Serum Aminotransferase Levels in Children at Risk for Obstructive Sleep ApneaChest 2008; 133(1): 92 doi: 10.1378/chest.07-0773
80
Madushika M. Wimalarathne, Quiana C. Wilkerson-Vidal, Emily C. Hunt, Sharifa T. Love-Rutledge. The case for FAT10 as a novel target in fatty liver diseasesFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.972320
81
Rania Abdel Rahman Elgawish, Haidy G. Abdel Rahman, Heba M.A. Abdelrazek. Green tea extract attenuates CCl4-induced hepatic injury in male hamsters via inhibition of lipid peroxidation and p53-mediated apoptosisToxicology Reports 2015; 2: 1149 doi: 10.1016/j.toxrep.2015.08.001
82
Mohammad Reza Alipour, Roya Naderi, Alireza Alihemmati, Roghayeh Sheervalilou, Rafighe Ghiasi. Swimming training attenuates pancreatic apoptosis through miR-34a/Sirtu in1/P53 Axis in high-fat diet and Streptozotocin-induced Type-2 diabetic ratsJournal of Diabetes & Metabolic Disorders 2020; 19(2): 1439 doi: 10.1007/s40200-020-00670-6
83
Arash Kheradmand, Omid Dezfoulian, Mohammad Javad Tarrahi. Ghrelin attenuates heat-induced degenerative effects in the rat testisRegulatory Peptides 2011; 167(1): 97 doi: 10.1016/j.regpep.2010.12.002
84
G. Song, H. Vollbrecht. Translating MicroRNAs to the Clinic2017; : 93 doi: 10.1016/B978-0-12-800553-8.00005-6
85
Sarah Zakaria, Rehab A. Hasan, Mona F. Mahmoud, Hassan M. El Fayoumi, Amr A. A. Mahmoud. The concurrent exposure to aluminium and fructose induces liver injury in rats: Protection by monoammonium glycyrrhizinateClinical and Experimental Pharmacology and Physiology 2020; 47(5): 809 doi: 10.1111/1440-1681.13257
86
Fatma Sayed Abdel-Aal Farag, Hend Mohamed Anwar, Tarek Aboushousha, Hala Sh. Mohammed, Lotfi Diab Mousa Ismail. Ameliorative Effects of Thunbergia erecta L. Leaves Against the Initiation of Hepatocarcinogenesis Induced by Diethylnitrosamine in the Rat ModelApplied Biochemistry and Biotechnology 2023; 195(10): 5881 doi: 10.1007/s12010-022-04292-x
87
David A. Areshidze, Maria A. Kozlova. Morphofunctional State and Circadian Rhythms of the Liver of Female Rats under the Influence of Chronic Alcohol Intoxication and Constant LightingInternational Journal of Molecular Sciences 2022; 23(18): 10744 doi: 10.3390/ijms231810744
88
Maria Jimena Amaya, Michael H. Nathanson. Comprehensive Physiology2013; : 515 doi: 10.1002/cphy.c120013